(ASTH) Astrana Health - Ratings and Ratios

Astrana Health, Inc. (NASDAQ:ASTH) operates as a healthcare management company, providing care coordination and medical services across the United States. The company is structured into three core segments: Care Partners, Care Delivery, and Care Enablement. These segments work collaboratively to deliver integrated healthcare solutions, focusing on improving patient outcomes and streamlining care processes. Astrana Healths services include care coordination, physician network management, and population health management, catering to a diverse range of stakeholders such as patients, families, primary care physicians, specialists, hospitals, physician groups, and health plans. The companys physician network includes primary care physicians, specialist physicians, extenders, and hospitalists, ensuring comprehensive coverage across various healthcare settings. Astrana Health serves patients with private or public insurance, including Medicare, Medicaid, and health maintenance organizations, as well as non-insured patients. Formerly known as Apollo Medical Holdings, Inc., the company rebranded as Astrana Health, Inc. in February 2024. Founded in 1994 and headquartered in Alhambra, California, Astrana Health has established itself as a key player in the healthcare services sector. Web URL: https://www.astranahealth.com

3-month forecast: Based on and , Astrana Health, Inc. (NASDAQ:ASTH) is expected to experience moderate price volatility with a potential downside bias. The stock is currently trading near its SMA 20 (31.36) and SMA 50 (31.00), with resistance at SMA 200 (42.27). The ATR of 1.75 suggests limited near-term volatility. Fundamentally, the companys P/E ratio of 34.33 indicates elevated valuations, while the forward P/E of 23.04 signals expectations of improving earnings. The P/S ratio of 0.69 suggests undervaluation relative to revenue, and the RoE of 6.05% reflects moderate profitability. Overall, the stock may consolidate near current levels, with potential support at $31.00 and resistance at $42.27.